Baxa Corporation Celebrates 30 Years of Product Safety and Innovation for Hospital Pharmacies
In March 1975, two entrepreneurs with experience in pharmacy sales and product development started Baxa Corporation, a medical device company focused on products that ensured patient safety. Thirty years later, the company’s first product – a dispenser dedicated to safe delivery of oral medications – is still the market leader, alongside a full line of devices and systems designed to streamline fluid drug handling, admixture and packaging activities in hospital and alternate-site pharmacies.
Englewood, CO (PRWEB) March 24, 2005
In March 1975, two entrepreneurs with experience in pharmacy sales and product development started Baxa Corporation, a medical device company focused on products that ensured patient safety. Thirty years later, the company’s first product – a dispenser dedicated to safe delivery of oral medications – is still the market leader, alongside a full line of devices and systems designed to streamline fluid drug handling, admixture and packaging activities in hospital and alternate-site pharmacies. Baxa Corporation saw organic growth in the 1970’s and early 1980’s through the development of close relationships with key national opinion leaders and the company’s dedication to understanding the needs of hospital pharmacists, and designing products that specifically addressed those sterile compounding needs.
The company’s second decade was characterized by organic expansion through market innovation, as it launched a series of unique products, such as the Repeater™ Pump – the first designed for accurate pharmacy filling. This was followed by the introduction of the MicroMacro™ Automated Compounders, the first to combine high speed for large-volume transfer, with accuracy for micro-ingredient delivery. By the end of its second decade, Baxa has added a dual rate syringe infuser and the Exacta-Mix™ Universal Pump to its line of products supporting pharmacy efficiency.
“It’s not thirty years of achievement that is so rewarding,” states Brian Baldwin, Founder and Chairman Emeritus, “It is the fun and excitement of the journey. My dream of building a truly great business is a continuous work in progress.” Brian and co-founder Ron Baxa both remain active in the business today, complementing the leadership of Brian’s sons Greg and Jeff Baldwin.
Through its focus on state-of-the-art technology for automating sterile compounding and improving other pharmacy procedures, Baxa Corporation gained a reputation as a leader in application knowledge and product innovation. That reputation led the companyÂ’s strategic growth in the 1990Â’s and allowed them to partner with companies such as Abbott Laboratories (now Hospira), Samson Technologies, Fujisawa and others to enhance the value of their product offering.
“Baxa always demonstrated technical expertise,” notes Jeff Baldwin, President and COO, “but it was our focus on customers that has built the business to what it is today. Targeting an underserved market and finding ways to change their operations to improve efficiencies has helped build a base of true Baxa “fans” in hospital pharmacies.”
Today, Baxa Corporation is nearing $100 million in annual sales, with 300 employees at its Englewood, Colorado headquarters. Reaching this 30-year anniversary milestone reflects the dedication of Baxa associates and the loyalty of the company’s customers worldwide. “Our mission,” says Greg Baldwin, Baxa Chairman and CEO, “has been to build lifelong customer relationships by providing the most innovative devices and systems for handling, packaging and administering liquid medications. Our success over the past 30 years is tangible proof that we are living that mission.”
About Baxa Corporation
Celebrating 30 years of business in 2005, Baxa Corporation is a Denver-based manufacturer of medical devices and systems for preparing, handling, packaging, and administering liquid medications. The company manufactures and markets a wide range of healthcare products for use in hospitals, critical care units and alternate-site pharmacies. Privately held, Baxa Corporation has subsidiaries and sales offices in Canada, the United Kingdom; Denmark and Germany; and distribution partners worldwide. Further information is available at http://www. baxa. com (http://www. baxa. com).
Contacts:
Marian Robinson, Vice President, Marketing
Baxa Corporation: 800.567.2292 ext. 2157 or 303.617.2157
Email: marian. robinson@baxa. com
Maggie Chamberlin Holben, APR
Absolutely Public Relations: 303.984.9801 or 303.669.3558
Email: maggie@absolutelypr. com
###
Link to CEO Greg Baldwin's Expert Profile at:
Http://expert411.com/_wsn/page7.html (http://expert411.com/_wsn/page7.html)
